Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.
Company to provide overview of Phase 2/3 LIFT-AD clinical trial of fosgonimeton in mild-to-moderate Alzheimer’s disease (AD); LIFT-AD topline data expected in second half of 2024 Two key opinion...
BOTHELL, Wash., June 11, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...
BOTHELL, Wash., May 29, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1 | 3.11526479751 | 3.21 | 3.47 | 3.0601 | 80037 | 3.2822606 | CS |
4 | 0.65 | 24.4360902256 | 2.66 | 3.6 | 2.43 | 140712 | 3.21205932 | CS |
12 | 1.31 | 65.5 | 2 | 3.6 | 1.935 | 143124 | 2.70055895 | CS |
26 | 0.23 | 7.46753246753 | 3.08 | 4.2984 | 1.895 | 248199 | 2.91557296 | CS |
52 | 0.55 | 19.9275362319 | 2.76 | 4.2984 | 1.33 | 243388 | 2.62370284 | CS |
156 | -6.93 | -67.67578125 | 10.24 | 16.65 | 1.33 | 344230 | 5.42519484 | CS |
260 | -16.64 | -83.4085213033 | 19.95 | 34.79 | 1.33 | 400426 | 9.00805156 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.